Virtual Medicinal Product (VMP) - Alogliptin 12.5mg tablets

Navigation

Name Details

Name Start Date End Date
Name Current Name Alogliptin 12.5mg tablets Start Date 05-12-2013 End Date

Unit Dose & Form Information

DF Indicator
Discrete
UDFS Indicator
1
UDFS UOM
tablet
Unit Dose UOM
tablet

Summary

Prescribing Status
Valid as a prescribable product
Controlled Drug Category
No Controlled Drug Status
Route
Oral
Form
Oral tablet
Ontology Form/Route
tablet.oral
Name Basis
rINN - Recommended International Non-proprietary

Codes

ATC Code
A10BH04
BNF Start Date End Date
Current BNF 06010203 Start Date 04-04-2022 End Date
Previous BNF 06010203 Start Date 25-06-2014 End Date 03-04-2022
SNOMED Codes
Code Start Date End Date
23637311000001105 05-12-2013

VMP Ingredients

VMP ingredients table
Name Basis of Strength Description BOSS Strength and UOM (Nmr) Strength and UOM (Dmr)
Alogliptin benzoate Based on Base Substance Alogliptin 12.5 mg

Parent Products

Virtual Medicinal Product Pack (VMPP) Information

Pack Size Drug Tariff Price Drug Tariff Payment Category
28 tablet 2660 Part VIIIA Category C